Specific treatment plans for lymphoma depend on the type and stage of disease. As our focus is on the biology of the cancers and their treatments, we do not give detailed treatment guidelines. Instead, we link to organizations in the U.S. that generate the treatment guidelines.
Radiation Therapy: Radiation is used to treat disease confined to one area of the body, often seen in patients with stage I or II lymphoma. Radiotherapy uses high energy rays to kill lymphoma cells. For more details view the section on Radiation Therapy
Chemotherapy: Often several chemotherapy drugs are given in combination. A combination commonly administered used to treat non-Hodgkin lymphoma is known as C.H.O.P., which includes cyclophosphamide (Cytoxan®, or Neosar®), doxorubicin or hydoxydoxorubicin (Adriamycin®), vincristine (Oncovin®) and prednisone.(1)For more details on this treatment view the section on Chemotherapy.
Antibody-based treatments: Antibodies are injected into the patient and recognize, bind and destroy lymphoma cells.(1) Rituximab (Rituxan®) is a human-mouse hybrid antibody that may be administered to lymphoma patients. It binds to a specific subset of B lymphocytes and causes their death.(2) Rituximab may be used alone or in conjunction with chemotherapy. For more details on this method view the section on Antibody-based treatment. Learn more about this drug from the manufacturer here.